Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2

The pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a serious global health threat. Since no specific therapeutics are available, researchers around the world screened compounds to inhibit various molecular targets of SARS-CoV-2 including its main protease (M(pro))...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, André, Sellner, Manuel, Mitusińska, Karolina, Bzówka, Maria, Lill, Markus A., Góra, Artur, Smieško, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922391/
https://www.ncbi.nlm.nih.gov/pubmed/33669738
http://dx.doi.org/10.3390/ijms22042065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922391/
https://www.ncbi.nlm.nih.gov/pubmed/33669738
http://dx.doi.org/10.3390/ijms22042065

Ejemplares similares